Max Planck Institute of Colloids and Interfaces

Search results

Journal Article (29)

  1. 1.
    Journal Article
    Brezesinski, G.; Calow, A. D. J.; Pereira, C. L.; Seeberger, P. H.: Thermodynamic and structural behaviour of α-Galactosylceramide and C6-functionalized α-GalCer in 2D layers at the air-liquid interface. ChemBioChem: A European Journal of Chemical Biology 21 (1-2), pp. 241 - 247 (2020)
  2. 2.
    Journal Article
    Parameswarappa, S. G.; Pereira, C. L.; Seeberger, P. H.: Synthesis of Streptococcus pneumoniae serotype 9V oligosaccharide antigens. Beilstein Journal of Organic Chemistry 16, pp. 1693 - 1699 (2020)
  3. 3.
    Journal Article
    Geißner, A.; Reinhardt, A.; Rademacher, C.; Johannssen, T.; Monteiro, J.; Lepenies, B.; Thépaut, M.; Fieschi, F.; Mrázková, J.; Wimmerova, M. et al.; Schuhmacher, F.; Götze, S.; Grünstein, D.; Guo, X.; Hahm, H. S.; Kandasamy, J.; Leonori, D.; Martin, C. E.; Parameswarappa, S. G.; Pasari,, S.; Schlegel, M. K.; Tanaka, H.; Xiao, G.; Yang, Y.; Pereira, C. L.; Anish, C.; Seeberger, P. H.: Microbe-focused glycan array screening platform. Proceedings of the National Academy of Sciences of the United States of America 116 (6), pp. 1958 - 1967 (2019)
  4. 4.
    Journal Article
    Schumann, B.; Reppe, K.; Kaplonek, P.; Wahlbrink, A.; Chakkumkal, A.; Witzenrath, M.; Pereira, C. L.; Seeberger, P. H.: Development of an efficacious, semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 1. ACS Central Science 4 (3), pp. 357 - 361 (2018)
  5. 5.
    Journal Article
    Qin, C.; Schumann, B.; Zou, X.; Pereira, C. L.; Tian, G.; Hu, J.; Seeberger, P. H.; Yin, J.: Total synthesis of a densely functionalized Plesiomonas shigelloides serotype 51 aminoglycoside trisaccharide antigen. Journal of the American Chemical Society 140 (8), pp. 3120 - 3127 (2018)
  6. 6.
    Journal Article
    Zou, X.; Qin, C.; Pereira, C. L.; Tian, G.; Hu, J.; Seeberger, P. H.; Yin, J.: Synergistic glycosylation as key to the chemical synthesis of an outer core octasaccharide of Helicobacter pylori. Chemistry – A European Journal 24 (12), pp. 2868 - 2872 (2018)
  7. 7.
    Journal Article
    Baek, J. Y.; Geissner, A.; Rathwell, D. C. K.; Meierhofer, D.; Pereira, C. L.; Seeberger, P. H.: A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate. Chemical Science 9 (5), pp. 1279 - 1288 (2018)
  8. 8.
    Journal Article
    Bröcker, F.; Götze, S.; Hudon, J.; Rathwell, D. C. K.; Pereira, C. L.; Stallforth, P.; Chakkumkal, A.; Seeberger, P. H.: Synthesis, liposomal formulation, and immunological evaluation of a minimalistic carbohydrate-α-GalCer vaccine candidate. Journal of Medicinal Chemistry 61 (11), pp. 4918 - 4927 (2018)
  9. 9.
    Journal Article
    Gerlach, D.; Guo, Y.; De Castro, C.; Kim, S.-H.; Schlatterer, K.; Xu, F.-F.; Pereira, C. L.; Seeberger, P. H.; Ali, S.; Codée, J. et al.; Sirisarn, W.; Schulte, B.; Wolz, C.; Larsen, J.; Molinaro, A.; Lee, B. L.; Xia, G.; Stehle, T.; Peschel, A.: Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity. Nature 563 (7733), pp. 705 - 709 (2018)
  10. 10.
    Journal Article
    Kaplonek, P.; Khan, N.; Reppe, K.; Schumann, B.; Emmadi, M.; Lisboa, M. P.; Xu, F.-F.; Calow, A. D. J.; Parameswarappa, S. G.; Witzenrath, M. et al.; Pereira, C. L.; Seeberger, P. H.: Improving vaccines against Streptococcus pneumoniae using synthetic glycans. Proceedings of the National Academy of Sciences of the United States of America 115 (52), pp. 13353 - 13358 (2018)
  11. 11.
    Journal Article
    Menova, P.; Sella, M.; Sellrie, K.; Pereira, C. L.; Seeberger, P. H.: Identification of the minimal glycotope of Streptococcus pneumoniae 7F capsular polysaccharide using synthetic oligosaccharides. Chemistry – A European Journal 24 (16), pp. 4181 - 4187 (2018)
  12. 12.
    Journal Article
    Emmadi, M.; Khan, N.; Lykke, L.; Reppe, K.; Parameswarappa, S.; Lisboa, M. P.; Wienhold, S.-M.; Witzenrath, M.; Pereira, C. L.; Seeberger, P. H.: A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. Journal of the American Chemical Society 139 (41), pp. 14783 - 14791 (2017)
  13. 13.
    Journal Article
    Lisboa, M. P.; Khan, N.; Martin, C.; Xu, F.-F.; Reppe, K.; Geissner, A.; Govindan, S.; Witzenrath, M.; Pereira, C. L.; Seeberger, P. H.: Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proceedings of the National Academy of Sciences of the United States of America 114 (42), pp. 11063 - 11068 (2017)
  14. 14.
    Journal Article
    Schumann, B.; Hahm, H. S.; Parameswarappa, S. G.; Reppe, K.; Wahlbrink, A.; Govindan, S.; Kaplonek, P.; Pirofski, L.-a.; Witzenrath, M.; Chakkumkal, A. et al.; Pereira, C. L.; Seeberger, P. H.: A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Science Translational Medicine 9 (380), eaaf5347 (2017)
  15. 15.
    Journal Article
    Seeberger, P. H.; Pereira, C. L.; Khan, N.; Xiao, G.; Diago-Navarro, E.; Reppe, K.; Opitz, B.; Fries, B. C.; Witzenrath, M.: A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae. Angewandte Chemie, International Edition in English 56 (45), pp. 13973 - 13978 (2017)
  16. 16.
    Journal Article
    Xu, F.-F.; Pereira, C. L.; Seeberger, P. H.: 1,3-Dibromo-5,5-dimethylhydantoin as promoter for glycosylations using thioglycosides. Beilstein Journal of Organic Chemistry 13, pp. 1994 - 1998 (2017)
  17. 17.
    Journal Article
    Bröcker, F.; Martin, C. E.; Wegner, E.; Mattner, J.; Baek, J. Y.; Pereira, C. L.; Chakkumkal, A.; Seeberger, P. H.: Synthetic lipoteichoic acid glycans are potential vaccine candidates to protect from Clostridium difficile infections. Cell Chemical Biology 23 (8), pp. 1014 - 1022 (2016)
  18. 18.
    Journal Article
    Geißner, A.; Pereira, C. L.; Leddermann, M.; Chakkumkal, A.; Seeberger, P. H.: Deciphering antigenic determinants of Streptococcus pneumoniae serotype 4 capsular polysaccharide using synthetic oligosaccharides. ACS Chemical Biology 11 (2), pp. 335 - 344 (2016)
  19. 19.
    Journal Article
    Möginger, U.; Resemann, A.; Martin, C. E.; Parameswarappa, S.; Govindan, S.; Wamhoff, E.-C.; Broecker, F.; Suckau, D.; Pereira, C. L.; Chakkumkal, A. et al.; Seeberger, P. H.; Kolarich, D.: Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports 6, 20488 (2016)
  20. 20.
    Journal Article
    Parameswarappa, S. G.; Reppe, K.; Geißner, A.; Ménová, P.; Govindan, S.; Calow, A. D. J.; Wahlbrink, A.; Weishaupt, M. W.; Monnanda, B. P.; Bell, R. et al.; Pirofski, L.-A.; Suttorp, N.; Sander, L.; Witzenrath, M.; Pereira, C. L.; Chakkumkal, A.; Seeberger, P. H.: A semi-synthetic oligosaccharide conjugate vaccine candidate confers protection against Streptococcus pneumoniae serotype 3 infection. Cell Chemical Biology 23 (11), pp. 1407 - 1416 (2016)
 
loading content
Go to Editor View